Skip to main content Back to Top
Advertisement

10/15/2021

Artesunate Injection

Products Affected - Description

    • Artesunate lyophilized powder for injection, Amivas, 110 mg, single dose vial, 2 count, NDC 73607-0011-11

Reason for the Shortage

    • Amivas has artenusate on shortage due to manufacturing delays.

Available Products

    • There are no presentations available

Estimated Resupply Dates

    • Amivas has artesunate on back order and the company estimates a release date of late-October 2021.

Alternative Agents & Management

    • Healthcare professionals who are unable to secure an emergency shipment of Artesunate for Injection via the usual distribution channels should contact the CDC (770-488-7788) Monday-Friday, 9 am-5 pm EST. Outside these hours, providers should call 770-488-7100.
    • See the CDC website for more information: www.cdc.gov/malaria/diagnosis_treatment/artesunate.html.

Updated

Updated October 15, 2021 by Anthony Trovato, PharmD, BCPS. Created September 14, 2021 by Stephen Andrews, PharmD, BCPS, Drug Information Specialist. © 2021, Drug Information Service, University of Utah, Salt Lake City, UT.

ADVERTISEMENT

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins


ahfs logo

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.